← All stocks

Health Catalyst, Inc.

HCAT Net selling
CIK 0001636422 #4210 in the set updated 17 Sep 2026
Bought (120 mo)
$6.03M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$98.25M
$1.69M on a plan · $87.44M straight out of an exercise
Sold at will
$9.12M
87 of 369 sales
Net
−$92.22M
−$3.09M against sales at will

By person

32 insiders · 403 transactions
4.7×

Daniel Burton holds only 4.7 times base salary in stock. $2.49M of shares against $525.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Burton last reported holding, valued at $1.79, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Burton Daniel D.
Chief Executive Officer
$5.75M (5)
$49.81M (41) scheduled
−$44.06M
1,393,099
1.85%
$2.49M
Nelli James Patrick Jr.
President
$10.83M (24) scheduled
−$10.83M
265,025
0.3522%
$473.63K
+3,977%
Horstmeier Paul
Chief Operating Officer
$10.74M (70) scheduled
−$10.74M
204,880
0.2722%
$366.14K
+1,280%
Pramoda Anita
Director
$7.41M (15) scheduled
−$7.41M
70,851
0.0941%
$126.62K
+458.1%
Sanders Dale
Chief Technology Officer
$5.57M (13) scheduled
−$5.57M
164,484
0.2186%
$293.95K
+173.8%
Orenstein Daniel H.
General Counsel
$4.78M (40) scheduled
−$4.78M
133,097
0.1769%
$237.86K
Llewelyn Linda
Chief People Officer
$3.73M (83) scheduled
−$3.73M
321,132
0.4267%
$573.89K
+200,608%
Ferris Timothy G.
Director
$1.18M (10) scheduled
−$1.18M
5,443
0.0072%
$9.73K
Bullock D Fraser
Director
$1.11M (5)
−$1.11M
44,999
0.0598%
$80.42K
Alger Jason
Chief Financial Officer
$776.42K (16)
−$776.42K
704,867
0.9366%
$1.26M
+6,134%
Hinton Bryan Richard
Chief Technology Officer
$673.85K (17)
−$673.85K
26,403
0.0351%
$47.18K
+5.6%
LeSueur Daniel
Chief Operating Officer
$649.85K (12) scheduled
−$649.85K
198,367
0.2636%
$354.50K
+84.5%
Landry Benjamin
General Counsel
$515.48K (12) scheduled
−$515.48K
351,372
0.4669%
$627.94K
+2,215%
Freeman Kevin Lee
Chief Commercial Officer
$170.26K (3)
−$170.26K
358,686
0.4766%
$641.01K
+486.5%
Larson-Green Julie
Director
$128.35K (1)
−$128.35K
185,101
0.2460%
$330.79K
Hunt Bryan Truman
Chief Financial Officer
$120.14K (5)
−$120.14K
219,849
0.2921%
$392.89K
+1,465%
Gallagher Duncan
Director
$174.95K (2)
$62.60K (2) scheduled
+$112.35K
132,023
0.1754%
$235.94K
Kohl Simeon
Chief Executive Officer
$105.44K (1)
+$105.44K
2,856,385
3.80%
$5.10M
+5,613%
HAQUE PROMOD
10% owner
4,707,737
6.26%
$8.41M
+292.7%
SC US (TTGP), LTD. entity
10% owner
3,707,029
4.93%
$6.62M
Norwest Venture Partners XI, LP entity
10% owner
3,504,304
4.66%
$6.26M
Albert Benjamin
CEO
1,388,406
1.84%
$2.48M
+1,152%
Cozzens Todd C
Director
1,371,348
1.82%
$2.45M
+275.3%
Nelson Steven H
Director
235,499
0.3129%
$420.86K
Ross David Coy
Chief Tech & Product Officer
204,219
0.2714%
$364.96K
−1.6%
KANE JOHN A
Director
170,719
0.2268%
$305.09K
+297.1%
Spencer Justin
Director
149,263
0.1983%
$266.75K
Hoggard Green Jill
Director
144,628
0.1922%
$258.46K
Smith S. Dawn
Director
101,692
0.1351%
$181.73K
Bickmore Anne Marie
COO and Chief Product Officer
63,720
0.0847%
$113.87K
+75.7%
Dixon Michael Edward
Director
54,199
0.0720%
$96.86K
TEMPLETON MARK B
Director
39,360
0.0523%
$70.34K
Insider
Date
Role
Action
Shares
Price
Amount
Kohl Simeon
14 Sep 2026
Chief Executive Officer
Buy
59,000
$1.79
$105.44K
Burton Daniel D.
27 Feb 2024
Chief Executive Officer
Buy
26,200
$7.81
$204.53K
Burton Daniel D.
12 May 2023
Chief Executive Officer
Buy
49,050
$10.19
$499.59K
Burton Daniel D.
11 Nov 2022
Chief Executive Officer
Buy
197,078
$10.14
$2.00M
Burton Daniel D.
8 Sep 2022
Chief Executive Officer
Buy
90,750
$10.99
$996.97K
Gallagher Duncan
19 Aug 2022
Director
Buy
6,600
$11.63
$76.75K
Gallagher Duncan
18 Aug 2022
Director
Buy
8,400
$11.69
$98.20K
Burton Daniel D.
9 Aug 2022
Chief Executive Officer
Buy
176,522
$11.62
$2.05M
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 513
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 236
Sales at will 87
Transactions with no price 0
Shares from compensation/vesting 42,418,557
Sales filed before the plan box existed 77
History held since 29 Jul 2019